These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27053534)

  • 21. [Nobel Prize 2007 for Medicine to Mario Capecchi, Martin Evans and Oliver Smithies: the mutant mice to order].
    Cohen-Tannoudji M
    Med Sci (Paris); 2007 Dec; 23(12):1159-61. PubMed ID: 18154719
    [No Abstract]   [Full Text] [Related]  

  • 22. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of the molecular biology underlying the pronounced high gene targeting frequency at the Myh9 gene locus in mouse embryonic stem cells.
    Tan L; Hu Y; Li Y; Yang L; Cai X; Liu W; He J; Wu Y; Liu T; Wang N; Yang Y; Adelstein RS; Wang A
    PLoS One; 2020; 15(3):e0230126. PubMed ID: 32226034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oliver Smithies (1925-2017).
    Sancar A
    Science; 2017 Feb; 355(6326):695. PubMed ID: 28209861
    [No Abstract]   [Full Text] [Related]  

  • 25. CRISPR-Cas9 technology and its application in haematological disorders.
    Zhang H; McCarty N
    Br J Haematol; 2016 Oct; 175(2):208-225. PubMed ID: 27619566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic editing of hepatocyte genome in vivo.
    Ruiz de Galarreta M; Lujambio A
    J Hepatol; 2017 Oct; 67(4):818-828. PubMed ID: 28527665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of designer nucleases for targeted gene and genome editing in plants.
    Weeks DP; Spalding MH; Yang B
    Plant Biotechnol J; 2016 Feb; 14(2):483-95. PubMed ID: 26261084
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Ma X; Wong AS; Tam HY; Tsui SY; Chung DL; Feng B
    Zool Res; 2018 Mar; 39(2):58-71. PubMed ID: 29515088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethical and regulatory aspects of genome editing.
    Kohn DB; Porteus MH; Scharenberg AM
    Blood; 2016 May; 127(21):2553-60. PubMed ID: 27053531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current status and recent advances of gene therapy in hematological diseases.
    Yamamoto M; Tani K
    Int J Hematol; 2016 Jul; 104(1):4-5. PubMed ID: 27250344
    [No Abstract]   [Full Text] [Related]  

  • 31. Delivery methods for site-specific nucleases: Achieving the full potential of therapeutic gene editing.
    Liu J; Shui SL
    J Control Release; 2016 Dec; 244(Pt A):83-97. PubMed ID: 27865852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Customizing the genome as therapy for the β-hemoglobinopathies.
    Canver MC; Orkin SH
    Blood; 2016 May; 127(21):2536-45. PubMed ID: 27053533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AAV Vectorization of DSB-mediated Gene Editing Technologies.
    Moser RJ; Hirsch ML
    Curr Gene Ther; 2016; 16(3):207-19. PubMed ID: 27280971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Nobel Prize in physiology or medicine 2007.
    Hansen T
    Scand J Immunol; 2007 Dec; 66(6):603. PubMed ID: 18021361
    [No Abstract]   [Full Text] [Related]  

  • 35. [Nobel Prize in medicine. Knockout mice revolutionize genetics].
    Schäfer C
    Unfallchirurg; 2007 Dec; 110(12):1082-4. PubMed ID: 18064505
    [No Abstract]   [Full Text] [Related]  

  • 36. A Method for Genome Editing in Human Pluripotent Stem Cells.
    Smith C; Ye Z; Cheng L
    Cold Spring Harb Protoc; 2016 Apr; 2016(4):pdb.prot090217. PubMed ID: 27037073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rabbit models for biomedical research revisited via genome editing approaches.
    Honda A; Ogura A
    J Reprod Dev; 2017 Oct; 63(5):435-438. PubMed ID: 28579598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oliver Smithies: born inventor.
    Williams R
    Circ Res; 2011 Mar; 108(6):650-2. PubMed ID: 21415407
    [No Abstract]   [Full Text] [Related]  

  • 39. CRISPR/Cas9 Gene Editing: From Basic Mechanisms to Improved Strategies for Enhanced Genome Engineering In Vivo.
    Salsman J; Masson JY; Orthwein A; Dellaire G
    Curr Gene Ther; 2017; 17(4):263-274. PubMed ID: 29173169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing.
    Amabile A; Migliara A; Capasso P; Biffi M; Cittaro D; Naldini L; Lombardo A
    Cell; 2016 Sep; 167(1):219-232.e14. PubMed ID: 27662090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.